Real-time enrollment status for this hepatocellular carcinoma (hcc) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:10 AM UTC
| NCT Number | NCT07291076 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma (HCC) |
| Phase | PHASE1 |
| Target Enrollment | 198 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07291076 is currently recruiting participants. This phase1 study for hepatocellular carcinoma (hcc) is actively seeking new participants at 11 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07291076 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07291076 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.